SOTYKTU (deucravacitinib) Patient Assistance Program
Don’t let the cost of brand specialty psoriasis therapy disrupt your treatment. We help eligible patients access Sotyktu (deucravacitinib) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey
- Annual Re-certification And Refills Management
- Medicare Part D Patients Accepted
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Sotyktu (deucravacitinib) is FDA-approved for adults with moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy. It is the first medicine in a newer drug class called TYK2 inhibitors and offers an oral alternative to injectable biologic therapies.
- Without assistance, the retail cost commonly runs $2,000–$2,400 per month, totaling roughly $24,000–$29,000 per year if treatment continues continuously.
- Through AffordMyPrescriptions, qualifying patients can access Sotyktu for a flat $69.95 per month — our advocacy team manages the entire enrollment, refills, and renewal process.
- There is no generic version of Sotyktu available in the U.S. as of 2026, and patent protections are expected to keep generic versions off the market for several more years.
What is Sotyktu Prescription Assistance Program?
The Sotyktu Prescription Assistance Program is a manufacturer-sponsored initiative that provides Sotyktu at little or no medication cost to qualifying patients based on income and insurance status. The program is designed for uninsured and underinsured individuals, as well as Medicare Part D beneficiaries who cannot afford specialty psoriasis therapy.
Navigating the program on your own means dealing with eligibility verification, dermatologist coordination, tuberculosis screening documentation, specialty pharmacy logistics, and renewal deadlines — all while managing a chronic skin condition that requires consistent daily therapy.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your enrollment, from initial application through ongoing refill coordination and annual re-certification — so you focus on your treatment, not paperwork.
Pharmacy Price Comparison
- Without assistance, Sotyktu costs roughly $2,000–$2,400 per month at retail pharmacies. Discount coupons offer some relief, but they don't come close to what a Patient Assistance Program provides — if you qualify:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens | ~$2,380.00 | Save ~$2,310/mo |
| CVS Pharmacy | ~$2,400.00 | Save ~$2,330/mo |
| Walmart | ~$2,150.00 | Save ~$2,080/mo |
| Costco | ~$2,050.00 | Save ~$1,980/mo |
| Kroger | ~$2,100.00 | Save ~$2,030/mo |
*Retail prices are estimates based on public data and vary by pharmacy. Coupon prices from GoodRx and SingleCare as of April 2026. Afford My Prescriptions Advocacy Service bypasses retail pricing by using drug manufacturer programs to secure your medication for you—independent of dosage or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Sotyktu Prescription Program?
The Patient Assistance Program is free to apply for and provides Sotyktu at little or no medication cost if approved. But the process involves detailed applications, dermatologist coordination, TB screening documentation, specialty pharmacy logistics, and ongoing renewal management. Our $69.95/month service covers full advocacy: applications, doctor coordination, documentation, refill management, and annual re-enrollment — so you focus on your health, not paperwork.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Sotyktu:
Limitations of Coupons
- Prices fluctuate — savings aren’t guaranteed month-to-month
Copay accumulators may prevent savings from counting toward your deductible
- Coupon cards expire and require constant renewal
Still $2,000–$2,400 per month even with the best discount
- Cannot be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
Medication supplied directly through the assistance program
- We manage all paperwork, refills, and annual renewals
Medicare Part D patients accepted
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Sotyktu assistance.
- You are a U.S. citizen or legal resident
- You Have A Valid Sotyktu Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured, Underinsured, Or A Medicare Part D Beneficiary
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Understanding Sotyktu:
Sotyktu (deucravacitinib) is a once-daily oral medicine for adults with moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy. It is the first FDA-approved medicine in the TYK2 inhibitor class and offers an oral alternative to injectable biologic therapies for many patients. Sotyktu is taken as one 6 mg tablet by mouth once daily, with or without food
How It Works:
Sotyktu is a first-of-its-kind TYK2 inhibitor that targets the immune signals responsible for plaque psoriasis. By binding to a specific part of the TYK2 enzyme, it dampens inflammatory messengers like IL-23 and IL-12 that cause skin cells to grow too quickly. Unlike JAK inhibitors, it works on a different signaling node, allowing it to calm immune drivers without the same boxed warnings associated with that class.
Form and Use:
The medication is taken as a single 6 mg tablet once daily, which can be consumed with or without food. The dosage is a fixed amount and does not need to be adjusted based on a patient’s body weight or kidney function. While no changes are needed for mild or moderate liver issues, the drug is not recommended for those with severe liver impairment.
Generic Availability:
As of 2026, there is no FDA-approved generic version of Sotyktu in the U.S., and patent protections are expected to last for several years. While no other TYK2 inhibitors are currently on the market, other oral and injectable therapies for psoriasis do exist as alternatives. To help with costs, the manufacturer reportedly offers a direct-to-patient program that provides the drug at a discount for eligible patients.
Warnings:
Patients must be screened for tuberculosis before starting treatment, as the drug affects immune-system signaling. While it lacks the severe boxed warnings of JAK inhibitors, it still requires routine medical monitoring to ensure safety. Common side effects may include upper respiratory infections, mouth ulcers, acne, and increased levels of CPK in the blood.
FAQ (Frequently Asked Questions)
How Much Does Sotyktu Cost Without Insurance?
The retail price for a 30-day supply at the standard 6 mg daily dose commonly runs $2,000–$2,400 per month. Coupon discounts at major pharmacies exist but are modest because the underlying price is high. Through AffordMyPrescriptions, qualifying patients receive Sotyktu at no medication cost — our $69.95 monthly fee covers full advocacy and program management.
Is Sotyktu A JAK Inhibitor?
No. Sotyktu is a TYK2 inhibitor, which is a different class of oral medicine. It works on a related but distinct signaling node and does not carry the same boxed warnings (for serious infections, cardiovascular events, malignancy, and thrombosis) that apply to JAK-class medicines. Your dermatologist can explain how this affects safety considerations for your specific situation.
Are There Cheaper Alternatives I Should Know About?
There are several. The manufacturer has reportedly launched a direct-to-patient cash-pay program offering Sotyktu at a substantial discount to eligible cash-paying patients. Older oral medicines such as methotrexate, apremilast (which is moving toward generic), and a range of injectable biologics with their own assistance programs are also options. We mention this directly because if a cheaper path on a different medicine would adequately treat your psoriasis, that may be a better fit than paying for our advocacy on brand Sotyktu.
Do I Need Any Tests Before Starting Sotyktu?
Yes. Patients are typically evaluated for active and latent tuberculosis before starting Sotyktu, since TYK2 inhibition can affect immune signaling. Your dermatologist will also review your medical history and current medications to decide whether Sotyktu is appropriate for you.
Can I Get Sotyktu Through The PAP If I Have Medicare?
Yes. Medicare Part D beneficiaries can typically qualify for Sotyktu Patient Assistance, especially if you face specialty-tier copays you cannot afford. The manufacturer’s commercial copay savings program ($0 per 30-day supply for eligible patients) is reserved for commercially insured patients only — but the underlying PAP supports Medicare patients who meet income criteria.
What if my application is denied?
If your initial application is denied, we explore alternative savings paths on your behalf — including the manufacturer’s direct-to-patient cash-pay program, the manufacturer’s copay savings program if you have commercial insurance, independent foundations such as the PAN Foundation or HealthWell Foundation for psoriasis-related funds, or asking your dermatologist whether a different oral or biologic psoriasis therapy would work for your situation. If we cannot find a path to medication access, you will not be charged our service fee.
Take Control of Your Medication Costs
If you are struggling with the high cost of Sotyktu, our team may be able to help you access assistance programs designed to make brand specialty psoriasis therapy affordable. Check your eligibility today and take the first step toward predictable, sustainable treatment.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.